Catastrophic catecholamine-induced cardiomyopathy rescued by extracorporeal membrane oxygenation in recurrent malignant pheochromocytoma
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Pheochromocytoma (PCC) is a rare catecholamine-producing tumor with the incidence in hypertension of 0.1-0.6%. PCC crisis is an endocrine emergency that can lead to hemodynamic disturbance and organ failure such as catecholamine-induced cardiomyopathy. The circulatory collapse caused by it often requires mechanical support. The author reports an unusual case in which a patient who previously underwent surgery for malignant PCC developed catecholamine-induced cardiomyopathy, and successfully recovered using extracorporeal membrane oxygenation.
Abstract
Pheochromocytoma (PCC) is a rare catecholamine-producing tumor with the incidence in hypertension of 0.1-0.6%. PCC crisis is an endocrine emergency that can lead to hemodynamic disturbance and organ failure such as catecholamine-induced cardiomyopathy. The circulatory collapse caused by it often requires mechanical support. The author reports an unusual case in which a patient who previously underwent surgery for malignant PCC developed catecholamine-induced cardiomyopathy, and successfully recovered using extracorporeal membrane oxygenation.
참고문헌 (18)
- Lenders JW, "Phaeochromocytoma", Lancet, 366, pp.665~675 (2005)
- Lenders JW, "Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline", J Clin Endocrinol Metab, 99, pp.1915~1942 (2014)
- Whitelaw BC, "Phaeochromocytoma crisis", Clin Endocrinol (Oxf), 80, pp.13~22 (2014)
- Prejbisz A, "Cardiovascular manifestations of phaeochromocytoma", J Hypertens, 29, pp.2049~2060 (2011)
- Il Woo Suh, "Catastrophic Catecholamine-Induced Cardiomyopathy Mimicking Acute Myocardial Infarction, Rescued by Extracorporeal Membrane Oxygenation (ECMO) in Pheochromocytoma", Journal of Korean Medical Science, 23(2), pp.350~354 (2008), 대한의학회
- Sojod G, "Successful extracorporeal membrane oxygenation treatment for pheochromocytoma-induced acute cardiac failure", Am J Emerg Med, 30, pp.1017.e1-3~ (2012)
- Giavarini A, "Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma", Heart, 99, pp.1438~1444 (2013)
- Otusanya O, "A vicious cycle of acute catecholamine cardiomyopathy and circulatory collapse secondary to pheochromocytoma", Oxf Med Case Reports, 2015, pp.343~345 (2015)
- Yi DW, "Pheochromocytoma crisis after a dexamethasone suppression test for adrenal incidentaloma", Endocrine, 37, pp.213~219 (2010)
- 안지영, "글루코코르티코이드 투여 후 반복적으로 유발된 갈색세포종 위기 1예", 대한내과학회지, 88(5), pp.564~569 (2015), 대한내과학회[DOI]
- Barrett C, "Risk of catecholaminergic crisis following glucocorticoid administration in patients with an adrenal mass: a literature review", Clin Endocrinol (Oxf), 83, pp.622~628 (2015)
- Tischler AS, "Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma cell cultures", J Neurochem, 40, pp.364~370 (1983)
- McMahon A, "Regulation of expression of dopamine beta-hydroxylase in PC12 cells by glucocorticoids and cyclic AMP analogues", J Neurochem, 59, pp.2040~2047 (1992)
- Yang S, "Glucocorticoids and vascular reactivity", Curr Vasc Pharmacol, 2, pp.1~12 (2004)
- Harari A, "Malignant pheochromocytoma: a review", Am J Surg, 201, pp.700~708 (2011)
- Baudin E, "Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma", Eur J Endocrinol, 171, pp.R111~R122 (2014)
- Tanaka S, "Malignant pheochromocytoma with hepatic metastasis diagnosed 20 years after resection of the primary adrenal lesion", Intern Med, 32, pp.789~794 (1993)
- Ilias I, "Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer", Semin Nucl Med, 41, pp.364~368 (2011)